A live-attenuated influenza vaccine for H3N2 canine influenza virus

Virology

Volumn 504, Issue , 2017, Pages 96-106

  Rodriguez, Laura ^a   Nogales, Aitor ^a   Reilly, Emma C ^a   Topham, David J ^a   Murcia, Pablo R ^b   Parrish, Colin R ^c   Martinez Sobrido, Luis ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

^c Cornell University ^*  (United States)

Author keywords

Attenuated (att); Canine influenza virus (CIV); Cold adapted (ca); Inactivated influenza vaccine (IIV); Influenza A virus (IAV); Live attenuated influenza vaccine (LAIV); Master donor virus (MDV); Reverse genetics techniques; Temperature sensitive (ts)

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; SIALIDASE; LIVE VACCINE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; CANINE INFLUENZA; CONTROLLED STUDY; EMBRYO; FEMALE; HA GENE; HIGH TEMPERATURE; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VIVO STUDY; INFLUENZA A (H3N2); INFLUENZA A (H3N8); INFLUENZA A VIRUS (H3N2); INFLUENZA A VIRUS (H3N8); INFLUENZA VACCINATION; LOW TEMPERATURE; MOUSE; NA GENE; NONHUMAN; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; BLOOD; C57BL MOUSE; CELL LINE; DOG; DOG DISEASES; GROWTH, DEVELOPMENT AND AGING; HEK293 CELL LINE; IMMUNOLOGY; MDCK CELL LINE; ORTHOMYXOVIRIDAE INFECTIONS; VIROLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE; DOG DISEASES; DOGS; FEMALE; HEK293 CELLS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H3N8 SUBTYPE; INFLUENZA VACCINES; MADIN DARBY CANINE KIDNEY CELLS; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; VACCINES, ATTENUATED; VIRUS REPLICATION;

EID: 85012303021     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2017.01.020     Document Type: Article

References (71)

1. Agency, E.M., 2014. Fluenz. Committee for Medicinal Products for Human Use (CHMP).
2. AVMA, 2016. Canine influenza. American Veterinary Medical Association.org.
3. Baker, S.F., Guo, H., Albrecht, R.A., Garcia-Sastre, A., Topham, D.J., Martinez-Sobrido, L., Protection against lethal influenza with a viral mimic. J. Virol. 87 (2013), 8591–8605.
4. Belongia, E.A., Kieke, B.A., Donahue, J.G., Greenlee, R.T., Balish, A., Foust, A., Lindstrom, S., Shay, D.K., Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004–2005 season to the 2006–2007 season. J. Infect. Dis. 199 (2009), 159–167.
5. Belshe, R.B., Edwards, K.M., Vesikari, T., Black, S.V., Walker, R.E., Hultquist, M., Kemble, G., Connor, E.M., Group, C.-T.C.E.S., Live attenuated versus inactivated influenza vaccine in infants and young children. N. Engl. J. Med. 356 (2007), 685–696.
6. Bunpapong N, N.N., Chaiwong, S., Tangwangvivat, R., Boonyapisitsopa, S., Jairak, W., Tuanudom, R., Prakairungnamthip, D., Suradhat, S., Thanawongnuwech, R., Amonsin, A., Genetic characterization of canine influenza A virus (H3N2) in Thailand. Virus Genes 48 (2014), 56–63.
7. Chan, W., Zhou, H., Kemble, G., Jin, H., The cold adapted and temperature sensitive influenza A/Ann Arbor/6/60 virus, the master donor virus for live attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature. Virology 380 (2008), 304–311.
8. Cheng, X., Zengel, J.R., Suguitan, A.L. Jr., Xu, Q., Wang, W., Lin, J., Jin, H., Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets. J. Infect. Dis. 208 (2013), 594–602.
9. Cox, A., Baker, S.F., Nogales, A., Martinez-Sobrido, L., Dewhurst, S., Development of a mouse-adapted live attenuated influenza virus that permits in vivo analysis of enhancements to the safety of live attenuated influenza virus vaccine. J. Virol. 89 (2015), 3421–3426.
10. Cox, M.M., Patriarca, P.A., Treanor, J., FluBlok, a recombinant hemagglutinin influenza vaccine. Influenza Other Respir. Virus. 2 (2008), 211–219.
11. Cox, N.J., Kitame, F., Kendal, A.P., Maassab, H.F., Naeve, C., Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2). Virology 167 (1988), 554–567.
12. Crawford, P.C., Dubovi, E.J., Castleman, W.L., Stephenson, I., Gibbs, E.P., Chen, L., Smith, C., Hill, R.C., Ferro, P., Pompey, J., Bright, R.A., Medina, M.J., Johnson, C.M., Olsen, C.W., Cox, N.J., Klimov, A.I., Katz, J.M., Donis, R.O., Transmission of equine influenza virus to dogs. Science 310 (2005), 482–485.
13. De Villiers, P.J., Steele, A.D., Hiemstra, L.A., Rappaport, R., Dunning, A.J., Gruber, W.C., Forrest, B.D., Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older. Vaccine 28 (2009), 228–234.
14. Dundon, W.G., De Benedictis, P., Viale, E., Capua, I., Serologic evidence of pandemic (H1N1) 2009 infection in dogs, Italy. Emerg. Infect. Dis. 16 (2010), 2019–2021.
15. Feng, K.H., Gonzalez, G., Deng, L., Yu, H., Tse, V.L., Huang, L., Huang, K., Wasik, B.R., Zhou, B., Wentworth, D.E., Holmes, E.C., Chen, X., Varki, A., Murcia, P.R., Parrish, C.R., Equine and canine influenza H3N8 viruses show minimal biological differences despite phylogenetic divergence. J. Virol. 89 (2015), 6860–6873.
16. Guo, H., Baker, S.F., Martinez-Sobrido, L., Topham, D.J., Induction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus. J. Virol. 88 (2014), 12006–12016.
17. Guo, Y., Wang, M., Kawaoka, Y., Gorman, O., Ito, T., Saito, T., Webster, R.G., Characterization of a new avian-like influenza A virus from horses in China. Virology 188 (1992), 245–255.
18. Hayward, J.J., Dubovi, E.J., Scarlett, J.M., Janeczko, S., Holmes, E.C., Parrish, C.R., Microevolution of canine influenza virus in shelters and its molecular epidemiology in the United States. J. Virol. 84 (2010), 12636–12645.
19. Hoft, D.F., Babusis, E., Worku, S., Spencer, C.T., Lottenbach, K., Truscott, S.M., Abate, G., Sakala, I.G., Edwards, K.M., Creech, C.B., Gerber, M.A., Bernstein, D.I., Newman, F., Graham, I., Anderson, E.L., Belshe, R.B., Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J. Infect. Dis. 204 (2011), 845–853.
20. Holt, D.E., Mover, M.R., Brown, D.C., Serologic prevalence of antibodies against canine influenza virus (H3N8) in dogs in a metropolitan animal shelter. J. Am. Vet. Med. Assoc. 237 (2010), 71–73.
21. Hussain, A.I., Cordeiro, M., Sevilla, E., Liu, J., Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells. Vaccine 28 (2010), 3848–3855.
22. JAVMA, Outbreak of canine influenza caused by new strain of virus. J. Am. Vet. Med. Assoc., 246, 2015, 1049.
23. Jeoung, H.Y., Lim, S.I., Shin, B.H., Lim, J.A., Song, J.Y., Song, D.S., Kang, B.K., Moon, H.J., An, D.J., A novel canine influenza H3N2 virus isolated from cats in an animal shelter. Vet. Microbiol. 165 (2013), 281–286.
24. Jin, H., Lu, B., Zhou, H., Ma, C., Zhao, J., Yang, C.F., Kemble, G., Greenberg, H., Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. Virology 306 (2003), 18–24.
25. Jin, H., Zhou, H., Lu, B., Kemble, G., Imparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A/Ann Arbor/6/60. J. Virol. 78 (2004), 995–998.
26. Julius S. Youngner, P.W.-D., Chambers, Thomas M., Keith E. Rushlow, R.S., Derivation and characterization of a live attenuated equine influenza vaccine virus. Am. J. Vet. Res. 62 (2000), 1290–1294.
27. Katsura, H., Iwatsuki-Horimoto, K., Fukuyama, S., Watanabe, S., Sakabe, S., Hatta, Y., Murakami, S., Shimojima, M., Horimoto, T., Kawaoka, Y., A replication-incompetent virus possessing an uncleavable hemagglutinin as an influenza vaccine. Vaccine 30 (2012), 6027–6033.
28. Kohlmeier, J.E., Woodland, D.L., Immunity to respiratory viruses. Annu. Rev. Immunol. 27 (2009), 61–82.
29. Lee, J.H., Pascua, P.N., Song, M.S., Baek, Y.H., Kim, C.J., Choi, H.W., Sung, M.H., Webby, R.J., Webster, R.G., Poo, H., Choi, Y.K., Isolation and genetic characterization of H5N2 influenza viruses from pigs in Korea. J. Virol. 83 (2009), 4205–4215.
30. Lin Y, Z.Y., Zeng, X., Lu, C., Liu, Y., Genetic and pathobiologic characterization of H3N2 canine influenza viruses isolated in the Jiangsu Province of China in 2009–2010. Vet. Microbiol. 158 (2012), 247–258.
31. Maassab, H.F., Plaque formation of influenza virus at 25 degrees C. Nature 219 (1968), 645–646.
32. Maassab, H.F., Bryant, M.L., The development of live attenuated cold-adapted influenza virus vaccine for humans. Rev. Med. Virol. 9 (1999), 237–244.
33. Martinez-Sobrido, L., Garcia-Sastre, A., Generation of recombinant influenza virus from plasmid DNA. J. Vis. Exp., 2010.
34. Meghan Ferris, M.D., 2012. Clinical review of supplemental biologics license application for MedImmune's quadrivalent live attenuated influenza vaccine (Q/LAIV). Department of Health & Human ServicesFDA/CBER/OVRR/DVRPA.
35. Morens, D.M., Taubenberger, J.K., Historical thoughts on influenza viral ecosystems, or behold a pale horse, dead dogs, failing fowl, and sick swine. Influenza Other Respir. Virus. 4 (2010), 327–337.
36. Murphy, B.R., Coelingh, K., Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines. Viral Immunol. 15 (2002), 295–323.
37. National Research Council (U.S.), 2011. Committee for the update of the guide for the care and use of laboratory animals. Institute for Laboratory Animal Research (U.S.), National Academies Press (U.S.), 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, D.C.
38. Nogales, A., Baker, S.F., Martinez-Sobrido, L., Replication-competent influenza A viruses expressing a red fluorescent protein. Virology 476C (2014), 206–216.
39. Nogales, A., Baker, S.F., Ortiz-Riano, E., Dewhurst, S., Topham, D.J., Martinez-Sobrido, L., Influenza A virus attenuation by codon deoptimization of the NS Gene for vaccine development. J. Virol. 88 (2014), 10525–10540.
40. Nogales, A., DeDiego, M.L., Topham, D.J., Martinez-Sobrido, L., Rearrangement of influenza virus spliced segments for the development of live-attenuated vaccines. J. Virol. 90 (2016), 6291–6302.
41. Nogales, A., Rodriguez, L., Chauche, C., Huang, K., Reilly, E.C., Topham, D.J., Murcia, P.R., Parrish, C.R., Martinez-Sobrido, L., A temperature sensitive live-attenuated canine influenza virus H3N8 vaccine. J. Virol., 2016.
42. Nogales, A., Huang, K., Chauche, C., DeDiego, M.L., Murcia, P.R., Parrish, C.R., Martinez-Sobrido, L., Canine influenza viruses with modified NS1 proteins for the development of live-attenuated vaccines. Virology 500 (2017), 1–10.
43. O'Neill, R.E., Talon, J., Palese, P., The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J. 17 (1998), 288–296.
44. Osterholm, M.T., Kelley, N.S., Sommer, A., Belongia, E.A., Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect. Dis. 12 (2012), 36–44.
45. Palese, P., Shaw, M.L., Fields Virology. Fifth ed., 2007, Lippincott Williams & Wilkins.
46. Pecoraro, H.L., Bennett, S., Huyvaert, K.P., Spindel, M.E., Landolt, G.A., Epidemiology and ecology of H3N8 canine influenza viruses in US shelter dogs. J. Vet. Intern. Med. 28 (2014), 311–318.
47. Pica, N., Palese, P., Toward a universal influenza virus vaccine: prospects and challenges. Annu. Rev. Med. 64 (2013), 189–202.
48. Powell, T.J., Silk, J.D., Sharps, J., Fodor, E., Townsend, A.R., Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunity. J. Virol. 86 (2012), 13397–13406.
49. Pronker, E.S., Claassen, E., Osterhaus, A.D., Development of new generation influenza vaccines: recipes for success?. Vaccine 30 (2012), 7344–7347.
50. Quinlivan, M., Zamarin, D., Garcia-Sastre, A., Cullinane, A., Chambers, T., Palese, P., Attenuation of equine influenza viruses through truncations of the NS1 protein. J. Virol. 79 (2005), 8431–8439.
51. Reilly, E.C., Lambert-Emo, K., Topham, D.J., The effects of acute neutrophil depletion on resolution of acute influenza infection, establishment of tissue resident memory (TRM), and heterosubtypic immunity. PLoS One, 11, 2016.
52. Snyder, M.H., Betts, R.F., DeBorde, D., Tierney, E.L., Clements, M.L., Herrington, D., Sears, S.D., Dolin, R., Maassab, H.F., Murphy, B.R., Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J. Virol. 62 (1988), 488–495.
53. Song, D., Kang, B., Lee, C., Jung, K., Ha, G., Kang, D., Park, S., Park, B., Oh, J., Transmission of avian influenza virus (H3N2) to dogs. Emerg. Infect. Dis. 14 (2008), 741–746.
54. Song, D., Moon, H.J., An, D.J., Jeoung, H.Y., Kim, H., Yeom, M.J., Hong, M., Nam, J.H., Park, S.J., Park, B.K., Oh, J.S., Song, M., Webster, R.G., Kim, J.K., Kang, B.K., A novel reassortant canine H3N1 influenza virus between pandemic H1N1 and canine H3N2 influenza viruses in Korea. J. Gen. Virol. 93 (2012), 551–554.
55. Song, D., Kim, H., Na, W., Hong, M., Park, S.J., Moon, H., Kang, B., Lyoo, K.S., Yeom, M., Jeong, D.G., An, D.J., Kim, J.K., Canine susceptibility to human influenza viruses (A/pdm 09H1N1, A/H3N2 and B). J. Gen. Virol. 96 (2015), 254–258.
56. Song, D.S., An, D.J., Moon, H.J., Yeom, M.J., Jeong, H.Y., Jeong, W.S., Park, S.J., Kim, H.K., Han, S.Y., Oh, J.S., Park, B.K., Kim, J.K., Poo, H., Webster, R.G., Jung, K., Kang, B.K., Interspecies transmission of the canine influenza H3N2 virus to domestic cats in South Korea, 2010. J. Gen. Virol. 92 (2011), 2350–2355.
57. Songserm T, A.A., Jam-on, R., Sae-Heng, N., Pariyothorn, N., Payungporn, S., Theamboonlers, A., Chutinimitkul, S., Thanawongnuwech, R., Poovorawan, Y., Fatal avian influenza A H5N1 in a dog. Emerg. Infect. Dis. 12 (2006), 1744–1747.
58. Su S, L.H., Zhao, F.R., Chen, J.D., Xie, J.X., Chen, Z.M., Huang, Z., Hu, Y.M., Zhang, M.Z., Tan, L.K., Zhang, G.H., Li, S.J., Avian-origin H3N2 canine influenza virus circulating in farmed dogs in Guangdong, China. Infect. Genet. Evol. 14 (2013), 444–449.
59. Su S, Z.P., Fu, X., Wang, L., Hong, M., Lu, G., Sun, L., Qi, W., Ning, Z., Jia, K., Yuan, Z., Wang, H., Ke, C., Wu, J., Zhang, G., Gray, G.C., Li, S., Virological and epidemiological evidence of avian influenza virus infections among feral dogs in live poultry markets, china: a threat to human health?. Clin. Infect. Dis. 58 (2014), 1644–1646.
60. Teng Q, Z.X., Xu, D., Zhou, J., Dai, X., Chen, Z., Li, Z., Characterization of an H3N2 canine influenza virus isolated from Tibetan mastiffs in China. Vet. Microbiol. 162 (2013), 345–352.
61. Tong, S., Zhu, X., Li, Y., Shi, M., Zhang, J., Bourgeois, M., Yang, H., Chen, X., Recuenco, S., Gomez, J., Chen, L.M., Johnson, A., Tao, Y., Dreyfus, C., Yu, W., McBride, R., Carney, P.J., Gilbert, A.T., Chang, J., Guo, Z., Davis, C.T., Paulson, J.C., Stevens, J., Rupprecht, C.E., Holmes, E.C., Wilson, I.A., Donis, R.O., New world bats harbor diverse influenza A viruses. PLoS Pathog., 9, 2013, e1003657.
62. Uraki, R., Kiso, M., Iwatsuki-Horimoto, K., Fukuyama, S., Takashita, E., Ozawa, M., Kawaoka, Y., A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges. J. Virol. 87 (2013), 7874–7881.
63. Victor, S.T., Watanabe, S., Katsura, H., Ozawa, M., Kawaoka, Y., A replication-incompetent PB2-knockout influenza A virus vaccine vector. J. Virol., 2012.
64. Waddell GH, T.M., Sigel, M.M., A new influenza virus associated with equine respiratory disease. J. Am. Vet. Med. Assoc. 143 (1963), 587–590.
65. Wang, H., Jia, K., Qi, W., Zhang, M., Sun, L., Liang, H., Du, G., Tan, L., Shao, Z., Ye, J., Cao, Z., Chen, Y., Zhou, P., Su, S., Li, S., Genetic characterization of avian-origin H3N2 canine influenza viruses isolated from Guangdong during 2006–2012. Virus Genes 46 (2013), 558–562.
66. Webster, R.G., Bean, W.J., Gorman, O.T., Chambers, T.M., Kawaoka, Y., Evolution and ecology of influenza A viruses. Microbiol. Rev. 56 (1992), 152–179.
67. WHO, 2013. Recommendations to assure the quality, safety and efficacy of influenza vaccines (human, live attenuated) for intranasal administration. WHO Technical Reports Series 977, pp. 153–227.
68. Wisconsin-Madison, S.M.S.O.V.M.U.O., 2016. UW Shelter Medicine, WVDL find canine influenza transmited to cats in Midwestern shelter.
69. Wong, S.S., Webby, R.J., Traditional and new influenza vaccines. Clin. Microbiol. Rev. 26 (2013), 476–492.
70. Yang X, L.C., Liu, F., Liu, D., Chen, Y., Zhang, H., Qu, L., Li, Y., Xia, D., Liu, M., Identification and genetic characterization of avian-origin H3N2 canine influenza viruses isolated from the Liaoning province of China in 2012. Virus Genes 49 (2014), 342–347.
71. Zhou, B., Li, Y., Speer, S.D., Subba, A., Lin, X., Wentworth, D.E., Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses. Vaccine 30 (2012), 3691–3702.